News About: R&D
Yungjin to launch generic ActosYungjin Pharm says it will launch the first generic version of Actos (pioglitazone hydrochloride), Glitzone 15 mg (823 won per tablet) from August 1.
Actos is a medication th...
|
Korea Kolmar to develop topical agent for treatment of osteoporosis
Korea Kolmar is aiming to develop a new topical drug containing calcitonin and bisphosphonates to treat osteoporosis by spending 3.5 billion won for the next three years, under the joint collaboration with the Korea R...
French research institute initiates combination study of clevudine and viread for HBV
Bukwang Pharm says the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), with the support of Pharmasset, Inc. and Gilead Sciences, Inc. has initiated the first head-to-head study of clevudine and...
Lotte Confectionary to sell new health supplements in August
Lotte Confectionary says it will market two functional gums, aiming to encourage managed cholesterol intake and anti-hangover at the end of next month.
"We will conduct many tests to prove that the newly invented h...
Hyundai launches immediate release allergy pillHyundai Pharm has marketed its immediate release form of Allerzone (cetirizine HCl 10 mg), a widely used allergy treatment, can be absorbed into the body as quickly as the origi...
|
Keunwha to introduce new medicines for aphthous ulcers
Keunwha Pharm signed a license-in agreement with the US based Uluru Inc. to distribute Uluru’s two new drugs for the treatment of aphthous ulcers - Aphthasol Paste and OraDisk A.
Aphthasol Paste contains 5% amlexan...
Chemically modified clopidogrel is on domestic marketHanmi Pharm says its chemically modified clopidogrel “Pidogle (clopidogrel napadisilate) tablets” are available in the domestic anti-clogging medicines market.
“We expect a p...
|
First generic Fosamax available on marketKwangdong Pharm says it has launched its generic version of Fosamax (alendronate) tablets, which are taken once a week.
"These approvals will provide generic options for pati...
|
Govert’s 10-year budget on new drug development totals 70 billion won
The government spent a mere 73.3 billion won to promote the domestic pharmaceutical industry's R&D new drug projects for the past 10 years, according to data released by the Korea Drug Research Association.
The KDR...
Ildong builds W16 bill. research centerIldong Pharm says it has invested 16.0 billion won to build its new research center at Dongtan New City of Kyunggi Province.
The Dongtan research center has about 7,670 sq. m...
|
